86Rb+ efflux mediated by α4β 2-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization

Biochemical Pharmacology

Volumn 80, Issue 8, 2010, Pages 1238-1251

  Marks, Michael J ^a   Meinerz, Natalie M ^a   Brown, Robert W B ^a   Collins, Allan C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytisine; Desensitization; Epibatidine; Methylcarbachol; Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

ACETYLCHOLINE; CYTISINE; EPIBATIDINE; METHYLCARBACHOL; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; RUBIDIUM 86; NICOTINIC AGENT; NICOTINIC RECEPTOR; RUBIDIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SYNAPTOSOME; CONTINUOUS INFUSION; DESENSITIZATION; DRUG BINDING; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SYNAPTOSOME; TRANSPORT AT THE CELLULAR LEVEL;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL TRANSPORT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; RUBIDIUM; SYNAPTOSOMES;

EID: 77956265854     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.06.040     Document Type: Article

References (67)

1. Quick M.W., Lester R.A. Desensitization of neuronal nicotinic receptors. J Neurobiol 2002, 53:457-478.
2. Fenster C.P., Rains M.F., Noerager B., Quick M.W., Lester R.A. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 1997, 17:5747-5759.
3. Lester R.A. Activation and desensitization of heteromeric neuronal nicotinic receptors: implications for non-synaptic transmission. Bioorg Med Chem Lett 2004, 14:1897-1900.
4. Paradiso K.G., Steinbach J.H. Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. J Physiol 2003, 553:857-871.
5. Wooltorton J.R., Pidoplichko V.I., Broide R.S., Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 2003, 23:3176-3185.
6. Fenster C.P., Whitworth T.L., Sheffield E.B., Quick M.W., Lester R.A. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 1999, 19:4804-4814.
7. + efflux from mouse brain synaptosomes. J Neurochem 1994, 63:2125-2135.
8. + efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 1996, 277:1383-1396.
9. Zwart R., Vijverberg H.P. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 1998, 54:1124-1131.
10. Nelson M.E., Kuryatov A., Choi C.H., Zhou Y., Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 2003, 63:332-341.
11. Zhou Y., Nelson M.E., Kuryatov A., Choi C., Cooper J., Lindstrom J. Human alpha4beta2 acetylcholine receptors formed from linked subunits. J Neurosci 2003, 23:9004-9015.
12. Moroni M., Bermudez I. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types. J Mol Neurosci 2006, 30:95-96.
13. + efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology 2007, 53:390-405.
14. Marks M.J., Whiteaker P., Calcaterra J., Stitzel J.A., Bullock A.E., Grady S.R., et al. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther 1999, 289:1090-1103.
15. + efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol 2008, 73:1796-1807.
16. Brown R.W., Collins A.C., Lindstrom J.M., Whiteaker P. Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem 2007, 103:204-215.
17. 125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 2004, 46:1141-1157.
18. Schwartz R.D., Kellar K.J. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 1983, 220:214-216.
19. Marks M.J., Burch J.B., Collins A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 1983, 226:817-825.
20. Whiteaker P., Marks M.J., Grady S.R., Lu Y., Picciotto M.R., Changeux J.P., et al. Pharmacological and null mutation approaches reveal nicotinic receptor diversity. Eur J Pharmacol 2000, 393:123-135.
21. 3H]nicotine eliminates low affinity binding. Life Sci 1990, 46:935-943.
22. 3H]nicotine binding to putative high affinity receptor sites in rat brain. Mol Pharmacol 1987, 31:392-400.
23. Bhat R.V., Marks M.J., Collins A.C. Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding. J Neurochem 1994, 62:574-581.
24. Katz B., Thesleff S. A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol 1957, 138:63-80.
25. Lester R.A., Dani J.A. Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J Neurophysiol 1995, 74:195-206.
26. Khiroug S.S., Khiroug L., Yakel J.L. Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes. Neuroscience 2004, 124:817-822.
27. Moroni M., Zwart R., Sher E., Cassels B.K., Bermudez I. alpha4beta2 Nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 2006, 70:755-768.
28. Carbone A.L., Moroni M., Groot-Kormelink P.J., Bermudez I. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol 2009, 156:970-981.
29. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999, 398:805-810.
30. Picciotto M.R., Zoli M., Lena C., Bessis A., Lallemand Y., Le Novere N., et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995, 374:65-67.
31. Ross S.A., Wong J.Y., Clifford J.J., Kinsella A., Massalas J.S., Horne M.K., et al. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 2000, 20:6431-6441.
32. Kuryatov A., Onksen J., Lindstrom J. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. Mol Pharmacol 2008, 74:132-143.
33. Mao D., Perry D.C., Yasuda R.P., Wolfe B.B., Kellar K.J. The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 2008, 104:446-456.
34. 125I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. J Neurochem 2002, 81:1102-1115.
35. Kuryatov A., Luo J., Cooper J., Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol 2005, 68:1839-1851.
36. Marks M.J., Wageman C.R., Grady S.R., Gopalakrishnan M., Briggs C.A. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. Biochem Pharmacol 2009, 78:795-802.
37. Rollema H., Coe J.W., Chambers L.K., Hurst R.S., Stahl S.M., Williams K.E. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci 2007, 28:316-325.
38. Tonstad S., Rollema H. Varenicline in smoking cessation. Expert Rev Respir Med 2010, 4:291-299.
39. Keating G.M., Lyseng-Williamson K.A. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Pharmacoeconomics 2010, 28:231-254.
40. Rowell P.P., Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem 1997, 68:1982-1989.
41. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992, 41:31-37.
42. Nashmi R., Xiao C., Deshpande P., McKinney S., Grady S.R., Whiteaker P., et al. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci 2007, 27:8202-8218.
43. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992, 12:2765-2784.
44. Benwell M.E., Balfour D.J., Anderson J.M. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem 1988, 50:1243-1247.
45. Breese C.R., Marks M.J., Logel J., Adams C.E., Sullivan B., Collins A.C., et al. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997, 282:7-13.
46. Perry D.C., Davila-Garcia M.I., Stockmeier C.A., Kellar K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999, 289:1545-1552.
47. Peng X., Gerzanich V., Anand R., Whiting P.J., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 1994, 46:523-530.
48. Gopalakrishnan M., Monteggia L.M., Anderson D.J., Molinari E.J., Piattoni-Kaplan M., Donnelly-Roberts D., et al. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther 1996, 276:289-297.
49. Whiteaker P., Sharples C.G., Wonnacott S. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 1998, 53:950-962.
50. Pauly J.R., Marks M.J., Gross S.D., Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 1991, 258:1127-1136.
51. Sanderson E.M., Drasdo A.L., McCrea K., Wonnacott S. Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 1993, 617:349-352.
52. Sparks J.A., Pauly J.R. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl) 1999, 141:145-153.
53. Nguyen H.N., Rasmussen B.A., Perry D.C. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 2003, 307:1090-1097.
54. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 1985, 45:427-433.
55. Buisson B., Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci 2001, 21:1819-1829.
56. Marks M.J., Stitzel J.A., Romm E., Wehner J.M., Collins A.C. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol 1986, 30:427-436.
57. Nashmi R., Lester H. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol 2007, 74:1145-1154.
58. Kishi M., Steinbach J.H. Role of the agonist binding site in up-regulation of neuronal nicotinic alpha4beta2 receptors. Mol Pharmacol 2006, 70:2037-2044.
59. Marks M.J., Grady S.R., Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 1993, 266:1268-1276.
60. Kuryatov A., Olale F.A., Choi C., Lindstrom J. Acetylcholine receptor extracellular domain determines sensitivity to nicotine-induced inactivation. Eur J Pharmacol 2000, 393:11-21.
61. Nguyen H.N., Rasmussen B.A., Perry D.C. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J Neurochem 2004, 90:40-49.
62. Mansvelder H.D., Keath J.R., McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 2002, 33:905-919.
63. Mao D., McGehee D.S. Nicotine and behavioral sensitization. J Mol Neurosci 2010, 40:154-163.
64. Xiao C., Nashmi R., McKinney S., Cai H., McIntosh J.M., Lester H.A. Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 2009, 29:12428-12439.
65. Picciotto M.R., Addy N.A., Mineur Y.S., Brunzell D.H. It is not " either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 2008, 84:329-342.
66. Hulihan-Giblin B.A., Lumpkin M.D., Kellar K.J. Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine. J Pharmacol Exp Ther 1990, 252:15-20.
67. Sharp B.M., Beyer H.S. Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther 1986, 238:486-491.